Scribe Therapeutics SCTX 深 滬
等待開盤 08-21 09:30:00 美东时间
32.83
+1.780
+5.73%
華盛通- 最 高39.60
- 今 開31.30
- 成交量 41.93万股
- 最 低 30.88
- 昨 收 31.05
- 總市值 5.77亿
- 52周最高 39.60
- 市盈率 靜 --
- 換手率 2.39%
- 52周最低 17.305
- 委 比 16.28%
- 總股本 1757.74万
- 歷史最高 39.60
- 量 比 1.64
- 振 幅 28.08%
- 歷史最低 17.305
- 每 手 1
- 風險率 3.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%
医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%，获私募巨头溢价34%收购；CDNL升逾15%，高管近日增持320万美元股份>>
08-19 16:11
美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
08-19 08:37
Guggenheim Initiates Coverage On Scribe Therapeutics with Buy Rating, Announces Price Target of $50
Guggenheim analyst Debjit Chattopadhyay initiates coverage on Scribe Therapeutics (NASDAQ:SCTX) with a Buy rating and announces Price Target of $50.
08-18 20:21
Scribe Therapeutics Updates Governance Following Initial Public Offering
The latest update is out from Scribe Therapeutics Inc. ( ($SCTX) ). On July 27,...
07-28 05:27
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
Scribe Therapeutics Inc. completed its upsized initial public offering, raising approximately $155.51 million by offering 9,867,000 shares at $15.00 per share. The company's common stock began trading on the Nasdaq Global Market under the ticker "SCTX." The offering was led by Leerink Partners, Goldman Sachs, Guggenheim Securities, and Wells Fargo Securities. Additionally, Scribe Therapeutics sold 500,000 shares in a concurrent private placement ...
07-27 20:05
